Bojungbangdocktang inhibits vascular endothelial growth factor induced angiogenesis via blocking the VEGF/VEGFR2 signaling pathway in human umbilical vein endothelial cells

Oriental herbal medicines have been widely used for the prevention or treatment of various diseases including cancer in Asia. However, to prove their chemo preventive efficacies in modern times, scientific evidence for those herbal medicines is required. Thus, in the present study, an effective herbal cocktail Bojungbangdocktang (BJBDT) was investigated to elucidate antiangiogenic mechanism in vitro and in vivo. BJBDT significantly inhibited vascular endothelial growth factor (VEGF) induced proliferation in HUVECs at nontoxic concentrations, despite weak cytotoxicity against human umbilical vein endothelial cells (HUVECs). BJBDT also significantly suppressed VEGF-induced migration and tube formation of HUVECs. Furthermore, BJBDT treatment resulted in pale color and low hemoglobin level in Matrigel plugs, as well as dark red color and high hemoglobin level in untreated control. Interestingly, BJBDT specifically inhibited the binding of VEGF to vascular endothelial growth factor receptor 2 (VEGFR2), but not VEGFR1. In addition, friedelin, formononetin, ginsenoside Rb1, naringin, atractyloside, diosgenin, and allantonin were identified from BJBDT by high-performance liquid chromatography (HPLC) analysis as a quality of control. Taken together, these results suggest that BJBDT is a potent angiogenesis inhibitor blocking the VEGF/VEGFR2 signaling pathway in HUVECs. Supported by the Korea Science and Engineering Foundation Grant from the Korean Government (Ministry of Science and Technology) (Grant No. R13-2007-019-00000-0)     

内皮细胞细胞外基质改性钛表面内皮细胞和血小板的生长行为

实验结合碱活化和钛表面原位构建人脐静脉内皮细胞(HUVECs)细胞外基质(extracellular matrix,ECM)的方法制备细胞外基质改性的粗糙钛片(Ti-OH-ECM),然后比较粗糙钛(Ti-OH)表面和光滑钛(Ti,对照组)表面构建ECM前后的表面形貌、亲疏水性变化、官能团表征、细胞相容性和血液相容性。结果表明,ECM在钛表面构建成功,粗糙钛表面接触角降低至9°,ECM改性后,粗糙钛片的接触角有显著的增高,具有统计学意义(P0.01);并且ECM在粗糙钛表面沉积的量显著大于对照组表面(P0.01);1 d和3 d的细胞荧光染色结果表明,粗糙钛表面抑制内皮细胞黏附,但是ECM改性后的粗糙钛表面内皮细胞黏附数量高于对照组改性后的表面,并且具有统计学意义(P0.05);与粗糙钛表面比较,ECM改性后的粗糙钛促进平滑肌细胞粘附及增殖;另外,2 h的血小板黏附结果表明,与对照组相比,粗糙钛的血小板黏附数量显著减少(P0.01),ECM改性后的粗糙钛表面进一步抑制血小板黏附及激活(P0.05)。因此,细胞外基质改性的碱活化钛为生物医疗器械提供了一定的研究基础。     

Fabrication and biological evaluation of polyether ether ketone(PEEK)/bioceramic composites

The repair of vascularized bone defects represents a significantly clinical challenge, and vascular regeneration is one of the necessary factors to promote bone tissue regeneration. To effectively repair large bone defects, new bone tissue must regenerate with a rich vascular network. Therefore, the development of biomaterials that can promote the regeneration of vascularized bone tissue is currently receiving attention from researchers. In this study, Li–Ca–Si bioceramics (LCS) containing Li, Ca, and Si elements was developed, then LCS was compounded with PEEK to prepare PEEK+10% LCS, PEEK+20% LCS, PEEK+30% LCS, and the effect of LCS-PEEK composite biomaterials on the proliferation and angiogenic ability of human umbilical vascular endothelial cells (HUVECs) further explored by Cell Counting Kit-8 (CCK-8), scanning electron microscope (SEM), quantitative real-time PCR (QPCR), Western Blotting and enzyme linked immunosorbent assay (ELISA). The results showed that HUVECs inoculated on 30%LCS ?+ ?PEEK material exhibited the best proliferation ability. And the adhesion ability of endothelial cells on PEEK gradually increased with the increase of LCS contents. Furthermore, the angiogenic ability of HUVECs on LCS-PEEK composites was examined using QPCR and Western blotting, and the results showed that the expression of angiogenic-related genes and proteins of HUVECs on PEEK composites gradually increased with increasing LCS concentration. These results demonstrated that the angiogenic ability of HUVECs was effectively stimulated by LCS-modified PEEK materials. The present results indicate that the PEEK material can be modified with bioceramics to promote angiogenesis, and this study lay the foundation for the subsequent development of scaffolds that promote vascularized bone tissue regeneration.     

黄连素调节eNOS/NO保护软脂酸诱导的HUVECs损伤作用机制研究

目的研究黄连素对软脂酸诱导人脐静脉内皮细胞(HUVECs)损伤的保护作用,并初步探讨其作用机制.方法采用500μmol/L软脂酸培养HUVECs 24 h,建立内皮细胞损伤模型,MTT法观察黄连素对细胞存活率的影响;检测细胞培养上清液中一氧化氮(NO)含量;RT-PCR法检测内皮型一氧化氮合酶(e NOS)mRNA水平;Western blot方法检测e NOS和磷酸化e NOS蛋白的表达.结果与对照组比较,软脂酸组细胞存活率降低(P0.05),培养液中NO含量下降(P0.05),细胞内e NOS mRNA水平、e NOS及磷酸化e NOS蛋白表达水平均显著下降(P0.01,P0.05).与软脂酸组比较,黄连素组细胞存活率增加,培养液中NO含量明显提高(P0.05),细胞内e NOS mRNA水平和磷酸化蛋白表达水平均显著提高(P0.01,P0.05).结论黄连素对软脂酸引起的血管内皮细胞损伤有显著的保护作用,并可能与上调e NOS、促进NO生成有关.     

人脐静脉内皮细胞培养液的选择

目的:筛选出人脐静脉内皮细胞(HUVECs)原代、传代最适培养液.方法:0.02%II型胶原酶灌注脐静脉消化15min获得细胞,用不同的培养液培养.24h后观察细胞贴壁状况,细胞计数法得到贴壁细胞数量;内皮细胞标志性蛋白vWF进行细胞鉴定.传代培养后,用MTT法比较不同培养液对HUVECs活力的影响.结果:用含ECGS、20%FBS的ECM组进行原代培养,可获得贴壁细胞数量最多的HUVECs,且与其他组间有显著差异;用含30ng·mL-1 VEGF165、10%FBS的M199进行传代培养,HUVECs活力较ECM组无明显差异.结论:HUVECs原代、传代培养分别选用优化后的培养液,既保证原代HUVECs的质量和数量,又使传代培养成本降低60.8%.